Jump to navigation

Draft pandemic treaty could force Big Pharma to share vaccines with developing countries

Major battles lie ahead as negotiations on a new treaty to set rules for production and distribution of life-saving drugs

Negotiations on protocols for a global and national level pandemic response have started with the World Health Organization's (WHO) Intergovernmental Negotiating Body's (INB) publication of a 'zero-draft' of a new pandemic treaty last week.

The draft states that the WHO is 'deeply concerned by the gross inequities' of supply, production and access to Covid-19 vaccines. Its proposal to reserve at least 20% of any tests, vaccines or treatments for use in poorer countries is likely to prompt major pushback from pharmaceutical giants.

Civil society groups say the treaty should compel governments to commit to sharing medical technology and knowhow. It also states that the intellectual property rules that uphold pharmaceutical company monopolies must be waived automatically when a health emergency is declared.

This points to the need for clear enforcement of the treaty which raises another raft of diplomatic questions. The WHO insists the treaty should be legally binding.

The draft cites the backdrop to its recommendations as the 'catastrophic failure of the international community in showing solidarity and equity in response to the novel Covid-19 pandemic'. The final draft is set to be presented at the World Health Assembly in 2024.

Other proposals in the draft include strengthening and sustaining capacities of health systems, cooperation for sustainable and predictable financing, and raising pandemic and public health literacy for pandemic prevention, preparedness, response and recovery.

It also calls for the establishment of the WHO Global Pandemic Supply Chain and Logistics Network to promote production and transfer of technology and know-how.

This network would boost research and development capacities and establish a Pathogen Access Benefit-Sharing System (PABS) to ensure equitable and timely sharing of pathogens with pandemic potential and genomic sequences.



Related Articles

Kudos to the health-workers

Despite grandstanding by some senior politicians, it is the doctors and nurses who are winning public support in the fight against the coronavirus

Criticisms are mounting about the lack of a coherent national strategy to manage the coronavirus pandemic. The missing piece is effective leadership from the national task force, under...


Vaccine shortfall risks spread of deadly new mpox strain

Disputes over pricing between Big Pharma and African states delayed response as did poor testing and surveillance

It took less than a year for the virus to resurface in Congo-Kinshasa after the World Health Organization (WHO) had announced in May 2023 that the global mpox...


Jab race hits new snag

Slow and unpredictable supplies and donations continue to disrupt the roll-out of Covid-19 vaccines in Africa. According to the World Health Organization, most vaccine donations have been 'ad...


Time to re-open

Africa’s lockdown era is nearing the end as policy-makers focus on how to live with Covid-19 rather than defeat it

The shadow-boxing over Covid-19 in Africa appears to be over. While retaining measures to protect public health wherever possible, the priority is now shifting to opening up economies...


First the good news…

Although Africa may escape the worst of the health emergency, concern is mounting about its effects on economies and public services

As Africa cautiously welcomes the positive news that it looks like it will escape the worst ravages of Covid-19 infections, it is also having to deal with the...